Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate

Vaccine

Volumn 21, Issue 17-18, 2003, Pages 1974-1979

  Chen, Hualan ^a,d   Subbarao, Kanta ^a,c   Swayne, David ^b   Chen, Qi ^a   Lu, Xiuhua ^a   Katz, Jacqueline ^a   Cox, Nancy ^a   Matsuoka, Yumiko ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Harbin Veterinary Research Institute   (China)

Author keywords

H9N2 subtype; Influenza virus; Pandemic influenza vaccine

Indexed keywords

ANTIBODY; FORMALDEHYDE; HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; DRUG EFFECT; DRUG SCREENING; EVALUATION; EXPERIMENTAL MODEL; FEMALE; FOWL; GENETIC REASSORTMENT; HONG KONG; INFLUENZA VIRUS A; INHIBITION KINETICS; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROVOCATION TEST; PUERTO RICO; VIROGENESIS; VIRUS EXAMINATION; VIRUS GENE; VIRUS HEMAGGLUTINATION; VIRUS STRAIN;

EID: 0037449093     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00809-5     Document Type: Article

References (18)

1. Horimoto T., Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin. Microbiol. Rev. 14:2001;129-149.
2. Webster R., Shortridge K., Kawaoka Y. Influenza: interspecies transmission and emergence of new pandemics. FEMS Immunol. Med. Microbiol. 18:1997;275-279.
3. Alexander D.J. A review of avian influenza in different bird species. Vet. Microbiol. 74:2000;3-13.
4. Claas E.C.J., Osterhaus A.D.M.E., Van Beek R.et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351:1998;472-477.
5. Subbarao K., Klimov A., Katz J.et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279:1998;393-396.
6. Subbarao K., Katz J. Avian influenza viruses infecting humans. Cell. Mol. Life Sci. 57:2000;1770-1784.
7. Peiris M., Yuen K.Y., Leung C.W.et al. Human infection with influenza H9N2. Lancet. 354:1999;916-917.
8. Guan Y., Shortridge K.F., Krauss S., Webster R.G. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc. Natl. Acad. Sci. U.S.A. 96:1999;9363-9367.
9. Guan Y., Shortridge K.F., Krauss S.et al. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J. Virol. 74:2000;9372-9380.
10. Guo Y., Krauss S., Senne D.A. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology. 267:2000;279-288.
11. Lin Y., Shaw M., Gregory V.et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9654-9658.
12. Guo Y., Li J., Cheng X.et al. Discovery of men infected by avian influenza A (H9N2) virus. Chin. J. Exp. Clin. Virol. 13:1999;105-108. (in Chinese).
13. Lu X., Tumpey T.M., Morken T., Zaki S.R., Cox N.J., Katz J.M. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:1999;5903-5911.
14. USAHA. Report of the Committee on Transmissible Diseases of Poultry and Other Avian Species. Criteria for determining that an AI virus isolation causing an outbreak must be considered for eradication. In: Proceedings of the 98th Annual Meeting of the U.S. Animal Health Association. Grand Rapids (MI): U.S. Animal Health Association; 1994. p. 522.
15. Lu X., Renshaw M., Tumpey T.M., Kelly G.D., Hu-Primmer J., Katz J.M. Immunity to influenza A H9N2 viruses induced by infection and vaccination. J. Virol. 75:2001;4896-4901.
16. Li S., Liu C., Klimov A., Subbarao K.et al. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179:1999;1132-1138.
17. Saito T., Lim W., Suzuki T., Suzuki Y., Kida H., Nishimura S.et al. Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine. 20:2002;125-133.
18. Meltzer M.I., Cox N.J., Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg. Infect. Dis. 5:1999;659-671.